The direct healthcare insurer and out-of-pocket expenditures of psoriasis: Evidence from a United States national survey

Journal of Dermatological Treatment

Volumn 23, Issue 4, 2012, Pages 240-254

  Gunnarsson, Candace ^a   Chen, Jie ^b   Rizzo, John A ^c   Ladapo, Joseph A ^d,e   Naim, Ahmad ^f   Lofland, Jennifer H ^f  

^a S2 Statistical Solutions Inc   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

^c STONY BROOK UNIVERSITY   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^f CENTOCOR INC   (United States)

Author keywords

Health expenditures; Healthcare costs; Psoriasis

Indexed keywords

ADULT; CAPITAL; FEMALE; HEALTH CARE COST; HEALTH INSURANCE; HEALTH SERVICE; HEALTH SURVEY; HUMAN; ICD-9-CM; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; PSORIASIS; RETROSPECTIVE STUDY; REVIEW; SELF REPORT; UNITED STATES;

COST OF ILLNESS; FEMALE; HEALTH CARE COSTS; HEALTH EXPENDITURES; HUMANS; INSURANCE CARRIERS; INSURANCE, HEALTH; LOGISTIC MODELS; MALE; MIDDLE AGED; PSORIASIS; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84863924270     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.3109/09546634.2010.550911     Document Type: Review

References (35)

1. Schön MP, Boehncke WH. Psoriasis. N Engl J Med. 2005; 352:1899-1912.
2. Horn EJ, Fox KM, Patel V, Chiou CF, Dann F, Lebwohl M. Are patients with psoriasis undertreated? Results of National Psoriasis Foundation survey. J Am Acad Dermatol. 2007;57:957-962.
3. Gelfand JM, Stern RS, Nijsten T, Feldman SR, Thomas J, Kist J, et al. The prevalence of psoriasis in African Americans: Results from a population-based study. J Am Acad Dermatol. 2005;52:23-26.
4. Koo J. Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment. Dermatol Clin. 1996; 14:485-496.
5. Stern RS, Nijsten T, Feldman SR, Margolis DJ, Rolstad T. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc. 2004;9:136-139.
6. Farber EM, Nall ML. The natural history of psoriasis in 5,600 patients. Dermatologica. 1974;148:1-18.
7. Rapp SR, Feldman SR, Exum ML, Fleischer AB Jr, Reboussin DM. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol. 1999; 41:401-407.
8. National Psoriasis Foundation. Benchmark Survey. Portland, OR: National Psoriasis Foundation; 2001.
9. de Arruda LH, De Moraes AP. The impact of psoriasis on quality of life. Br J Dermatol. 2001;144:33-36.
10. Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med. 2009;361:496-509.
11. Finlay AY, Coles EC. The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol. 1995;132: 236-244.
12. Javitz HS, Ward MM, Farber E, Nail L, Vallow SG. The direct cost of care for psoriasis and psoriatic arthritis in the United States. J Am Acad Dermatol. 2002;46: 850-860.
13. United States Department of Labor, Bureau of Labor Statistics. Consumer Price Index Archived News Releases. Available from: http://www.bls.gov/schedule/ archives/cpi-nr.htm (Accessed 2009 November 14
14. Simpson GL, Yelverton CB, Rittenberg S, Feldman SR. Do utilization management controls for phototherapy increase the prescription of biologics? J Dermatolog Treat. 2006;17: 359-361.
15. Fowler JF, Duh MS, Rovba L, Buteau S, Pinheiro L, Lobo F, et al. The impact of psoriasis on health care costs and patient work loss. J Am Acad Dermatol. 2008;59: 772-780.
16. Berger K, Ehlken B, Kugland B, Augustin M. Cost-ofillness in patients with moderate and severe chronic psoriasis vulgaris in Germany. J Dtsch Dermatol Ges. 2005; 3:511-518.
17. Jenner N, Campbell J, Plunkett A, Marks R. Cost of psoriasis: A study on the morbidity and financial effects of having psoriasis in Australia. Australas J Dermatol. 2002;43: 255-261.
18. Beyer V, Wolverton SE. Recent trends in systemic psoriasis treatment costs. Arch Dermatol. 2010;146:46-54.
19. Agency for Healthcare Research and Quality (AHRQ). Medical Expenditure Panel Survey. Available from: http://www. meps.ahrq.gov/mepsweb (Accessed 2010 April 14
20. Cohen JW, Monheit AC, Beauregard KM, Cohen SB, Lefkowitz DC, Potter DE, et al. The Medical Expenditure Panel Survey: A national health information resource. Inquiry. 1996-1997;33:373-389.
21. Agency for Healthcare Research and Quality (AHRQ). MEPS-HC Panel Design and Collection Process. Available from: http://www.meps.ahrq.gov/survey-comp/hc- data-collection. jsp (Accessed 2010 April 14
22. Lee DW, Meyer JW, Clouse J. Implications of controlling for comorbid conditions in cost-of-illness estimates: A case study of osteoarthritis from a managed care system perspective. Value Health. 2001;4:329-334.
23. Cragg JG. Some statistical models for limited dependent variables with application to the demand for durable goods. Econometrica. 1971;39:829-844.
24. Buntin M, Zaslavsky A. Too much ado about two-part models and transformation? Comparing methods of modeling Medicare expenditures. J Health Econ. 2004;23: 525-542.
25. Mullahy J. Much ado about two: Reconsidering retransformation and the two-part model in health econometrics. J Health Econ. 1998;17:247-281.
26. Kotlarz H, Gunnarsson CL, Fang H, Rizzo JA. Insurer and out-of-pocket costs of osteoarthritis in the US: Evidence from national survey data. Arthritis Rheum. 2009;60: 3546-3553.
27. U.S. Bureau of the Census. Population estimates. Available from: http://www.census.gov/popest/national/national.html (Accessed 2010 April 14
28. Icen M, Crowson CS, McEvoy MT, Dann FJ, Gabriel SE, Maradit Kremers H. Trends in incidence of adult-onset psoriasis over three decades: A population-based study. J Am Acad Dermatol. 2009;60:394-401.
29. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. National Diabetes Fact Sheet: General information and national estimates on diabetes in the United States, 2007. Available from: http:// www.cdc.gov/diabetes/pubs/pdf/ndfs-2007.pdf (Accessed 2010 April 14
30. National Institutes of Health. Incidence and Prevalence: 2006 Chart Book on Cardiovascular and Lung Diseases. Bethesda, MD: National Heart, Lung and Blood Institute; May 2006. Available from: http://www.nhlbi.nih.gov/ resources/docs/06a-ip-chtbk.pdf (Accessed 2010 April 14
31. United States Department of Labor, Bureau of Labor Statistics. National Compensation Survey: Occupational Wages in the United States, July 2003 (Bulletin 2568). September 2004. Available from: http://stats.bls.gov/ncs/ocs/ sp/ncbl0658.pdf (Accessed 2010 April 14
32. Blumenthal D. Employer-sponsored insurance- Riding the health care tiger. N Engl J Med. 2006;355: 195-202.
33. Blumenthal D. Employer-sponsored health insurance in the United States-Origins and implications. N Engl J Med. 2006;355:82-88.
34. Collins SR, Davis K, Ho A. A shared responsibility. US employers and the provision of health insurance to employees. Inquiry. 2005;42:6-15.
35. Machlin S, Cohen J, Elixhauser A, Beauregard K, Steiner C. Sensitivity of household reported medical conditions in the medical expenditure panel survey. Med Care. 2009;47:618-625.